Filter posts

Kenneth Thorpe: America Subsidizes Medical Innovation for World

Kenneth Thorpe, chairman of the Partnership to Fight Chronic Disease and a former deputy assistant …

Center for Medicine in the Public Interest Challenges Accuracy of 60 Minutes Cancer Story

This week, the Center for Medicine in the Public Interest issued a press release criticizing …

Tekmira CEO Discusses Ebola Therapy Development at 2014 BIO Investor Forum

Today at the 13th Annual BIO Investor Forum, Tekmira CEO Dr. Mark Murray participated in a …

T-Cell Therapies: Best Bets in Pushing Down the Cost Curve and Prioritizing Cancer Targets

New approaches in cancer immunology are achieving promising early-stage results through novel techniques for arming …

Gates Foundation and Grand Challenge Partners Announce New Investments in Breakthrough Science

At an event in Seattle today, the Bill & Melinda Gates Foundation and a group …

New PhRMA report: Nearly 800 Cancer Medicines in Development

A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) shows that biopharma …

Washington Post: Why Extremely Expensive Drugs Are Often Worth the Cost

Jason Millman highlights a new study published in Health Affairs showing specialty drugs often provide …

Health Affairs: 5 Myths about Cancer Care in America

In the latest issue of Health Affairs, Dana Goldman of the University of Southern California …

Cancer drugs save and extend lives

This week, CBS aired a misleading segment on the cost of innovative cancer therapies. BIO …

5 Priorities for Reducing Infant Mortality

In the U.S., the number of babies who die in their first year of life …